Pacific Capital Partners LTD Axonics, Inc. Transaction History

Pacific Capital Partners LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 May 08, 2025	BUY	$67.3 - $69.67 $1.14 Million - $1.18 Million	16,872 New	16,872 $1.17 Billion
Q1 2024 May 08, 2025	SELL	$56.67 - $69.36 $425,478 - $520,754	-7,508 Reduced 30.8%	16,872 $1.16 Billion
Q4 2023 May 08, 2025	BUY	$49.38 - $63.75 $49,380 - $63,750	1,000 Added 4.28%	24,380 $1.52 Billion
Q3 2023 May 08, 2025	BUY	$48.64 - $62.51 $1.14 Million - $1.46 Million	23,380 New	23,380 $1.31 Billion

4.99M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Pacific Capital Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Pacific Capital Partners LTD with notifications on news.